Skip to content
10-Q

Quarterly Report

AVENUE THERAPEUTICS, INC. ATXI

0001437749-25-017180

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 14, 2025 3.18M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $3.5M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $2.59M
Stockholders Equity Q1 2025 · Mar 31, 2025 $3.51M
Stockholders Equity Q1 2025 · Dec 31, 2024 $2.8M
Current Liabilities Q1 2025 · Mar 31, 2025 $1.26M
Current Liabilities Q1 2025 · Dec 31, 2024 $816K
Total Liabilities Q1 2025 · Mar 31, 2025 $1.26M
Total Liabilities Q1 2025 · Dec 31, 2024 $816K
Total Assets Q1 2025 · Mar 31, 2025 $3.59M
Total Assets Q1 2025 · Dec 31, 2024 $2.67M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$3.12M
Eps Basic Q1 2025 · Mar 31, 2024 −$15.40
Sga Expense Q1 2025 · Mar 31, 2024 $1.32M
Rd Expense Q1 2025 · Mar 31, 2024 $2.39M
Net Income Q1 2025 · Mar 31, 2024 −$4.34M
Operating Income Q1 2025 · Mar 31, 2024 −$3.71M